The global aplastic anemia market is poised for sustained growth, driven by robust research and development efforts, new product launches, and regulatory support for treatment advancements. According to the latest market report, the global aplastic anemia industry was valued at US$ 6.7 billion in 2023, and is projected to grow at a CAGR of 4.3% from 2024 to 2034, reaching a valuation of US$...